Trump Trade: Trump mulls bailout of $10B or more for U.S. farmers

Catch up on the top industries and stocks that were impacted, or were predicted to be impacted, by the comments, actions and policies of President Donald Trump with this daily recap compiled by The Fly:

FARMER BAILOUT: President Trump is weighing giving at least $10B in aid to U.S. farmers as the agriculture sector warns of economic fallout from his broad slate of tariffs, the Wall Street Journal’s Brian Schwartz, Patrick Thomas, and Natalie Andrews report, citing people familiar with the discussions. The president and his team are considering using tariff revenue to fund a good portion of the aid, the authors note. Publicly traded companies in the space include Andersons (ANDE), Archer Daniels (ADM), Bunge (BG), CF Industries (CF), Compass Minerals (CMP), Intrepid Potash (IPI) and Mosaic (MOS).

CLOSE COMMUNICATION: USA Rare Earth (USAR) CEO Barbara Humpton told CNBC on Thursday that the company is in “close communication” with the White House. “We are in close communication with the administration,” Humpton told CNBC’s Morgan Brennan when asked whether USA Rare Earth was interested in a deal with the Trump administration. “This is a field where it will not be a zero sum game,” Humpton said of the rare earth supply chain. “It’s going to take a lot of players to build out this marketplace.” Humpton’s comments comes after the Trump administration took a 5% equity stake in Lithium Americas (LAC) this week, while the Defense Department took a 15% stake in MP Materials (MP) in July.

DRUG-PRICING DEAL: All major pharmaceutical companies were told by the Trump administration that they needed to lower their prices and manufacture in the U.S., or face consequences such as tariffs, Liz Essley Whyte, Jonathan Rockoff, and Peter Loftus of The Wall Street Journal report. Pfizer (PFE) CEO Albert Bourla and Chris Klomp, head of Medicare, who was leading negotiations for the administration, met in Washington and reached a handshake agreement, with talks intensifying the week of September 20. The final deal was entered the morning prior to the deadline and was signed by Bourla and Health Secretary Robert Kennedy Jr. just ahead of the tariff announcement, people familiar with the deal said. Pfizer ended up avoiding tariffs while seeing its bottom line minimally hit.